Clinical Trial Update: Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin for preventing glucocorticoid-induced diabetes in patients with brain metastases, with melanoma context.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Melanoma

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Brain Metastases, Melanoma | Phase 2 | Status: UNKNOWN